Klinične študije za Migrena v Michigan
6 študij za Migrena išče udeležence na lokacijah v Michigan.
Mesta v Michigan
Uradno besedilo študije (angleško)
Study of EVO756 in Adults With Migraine
- Michigan Headache and Neurological Institute, Ann Arbor
- Quest Research Institute-Alcanza, Farmington Hills
Vključevanje udeležencevFaza 2
Starost 18–64 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07616128Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- NRST - Detroit, Detroit
Vključevanje udeležencevFaza 3
Starost 6–17 · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT05156398Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Michigan Head Pain and Neurological Institute, Ann Arbor
- Corewell Health, for and on behalf of Spectrum Health Hospital and Corewell Health Medical Group, Grand Rapids
- Corewell Health, Helen DeVos Children's Hospital, Grand Rapids
- in še 1
Vključevanje udeležencevFaza 3
Starost 6–17 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Michigan Head Pain & Neurological Institute, Ann Arbor
- Corewell Health, for and on behalf of Spectrum Health Hospital and Corewell Health Medical Group, Grand Rapids
- Corewell Health, Helen DeVos Children's Hospital, Grand Rapids
- in še 1
Vključevanje udeležencevFaza 3
Starost 6–17 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT04649242A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Michigan Headache & Neurological Institute /ID# 270942, Ann Arbor
Vključevanje udeležencevFaza 3
Starost 12–17 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT06810505A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Michigan Headache Pain & Neurological Institute, Ann Arbor
Vključevanje udeležencevFaza 3
Starost 18–75 · Vsi spoli · Posodobljeno 20. avg. 2026 · NCT07645924Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.